ArticleNew genetics and society2015
Closure of a human tissue biobank: individual, institutional, and field expectations during cycles of promise and disappointment.
Article in New genetics and society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- When genomics companies act as biobanks: governance challenges in an era of genomic assetization.Frontiers in genetics · 2026Article
- The politics of suspension suspended: the curious case of a cryopreserved cell product.BioSocieties · 2024Article
- Priorities in Biobanking Research: A Report on the 2021 ISBER Round Table.Biopreservation and biobanking · 2023Article
- Join our team, change the world: edibility, producibility and food futures in cultured meat company recruitment videos.Food, culture, & society · 2022Article
- The Availability of Human Biospecimens to Support Biomarker Research.Biomarker insights · 2022Review
- Recommendations for a Dutch Sustainable Biobanking Environment.Biopreservation and biobanking · 2021Article
- Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic.Biomarker insights · 2021Article
- The reconfiguration of biobanks in Europe under the BBMRI-ERIC framework: towards global sharing nodes?Life sciences, society and policy · 2020Article
- Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.Journal of translational medicine · 2020Article
- Blood, meat, and upscaling tissue engineering: Promises, anticipated markets, and performativity in the biomedical and agri-food sectors.BioSocieties · 2018Article
- Balancing the local and the universal in maintaining ethical access to a genomics biobank.BMC medical ethics · 2017Review
- Article
- "Forward-Thinking" in U.S. Biobanking.Genetic testing and molecular biomarkers · 2017Article
- Quality Assurance in Biobanking for Pre-Clinical Research.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2016Review
- Unexpected tissue and the biobank that closed: an exploration of value and the momentariness of bio-objectification processes.Life sciences, society and policy · 2015Article
- Supporting Stewardship: Funding, Utilization, and Sustainability as Ethical Concerns in Networked Biobanking.AJOB empirical bioethicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biobanks are increasingly being established to act as mediators between patient-donors and researchers. In practice, some of these will close. This paper details the experiences of one such bank. We report interviews with the bank's staff and oversight group during the period when the bank ceased biobanking activity, reconfigured as a disseminator of best practice, before then closing altogether. The paper makes three distinct contributions: (i) to provide a detailed account of the establishment, operational challenges, and eventual closure of the bank, which makes clear the rapid turnover in a cycle of promise and disappointment; (ii) to explore this in terms of a novel analytical focus upon field, institutional, and individual expectations; and (iii) to use this typology to demonstrate how, even after the bank's closure, aspects of its work were reconfigured and reused in new contexts. This provides a unique empirical analysis of the under-reported issue of biobank closure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.